Author Interviews, Cannabis / 17.09.2021
Withdrawal from Synthetic Cannabinoids Rated Worse Than From Cannabis
MedicalResearch.com Interview with:
Sam Craft
Addiction and Mental Health Group (AIM), Department of Psychology,
University of Bath, Bath
National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience
King’s College London, London
UK
MedicalResearch.com: What is the background for this study?
Response: Synthetic cannabinoid receptor agonists (SCRAs, also known as Spice or K2) are a group of synthetic drugs originally produced to mimic the effects of cannabis. As they are often more accessible or cheaper and cannot be detected on drugs tests, SCRAs may be used as an alternative to cannabis. However, although they act on the same receptors – cannabinoid receptor type 1 and 2 (CBR1; CBR2) – SCRAs are far more potent than cannabis which may make them more addictive and increase the severity of withdrawal (unpleasant symptoms experienced after cessation of a drug which has been used in large amounts for a long period of time)
As part of the Global Drug Survey, in this study we asked participants who use both SCRAs and cannabis to compare their effects across different measures which indicate how likely a drug is to result in long-term harm. For example, how severe withdrawal symptoms are and how long the effects last. We also asked participants which withdrawal symptoms they experienced when attempting to stop. (more…)